HIV-1 integrase crosslinked oligomers are active in vitro

Area of Science:

• Biochemistry
• Molecular Biology
• Virology

Background:

• The precise oligomeric state of active human immunodeficiency virus type 1 integrase (HIV-1 IN) remains unclear.
• Understanding the functional oligomeric states of HIV-1 IN is crucial for developing effective antiviral therapies.

Purpose of the Study:

• To determine the oligomeric state of HIV-1 IN responsible for its catalytic activity.
• To elucidate the role of different HIV-1 IN oligomers in viral DNA integration.

Main Methods:

• Purification and stabilization of recombinant HIV-1 IN using platinum crosslinking.
• Isolation of different oligomeric forms (tetramer, dimer) via gel chromatography.
• In vitro integration assays using viral LTRs and target DNA.
• Cloning, sequencing, and kinetic studies of DNA-integrase complexes.

Main Results:

• The purified tetrameric form of HIV-1 IN catalyzed full-site integration of both viral LTR ends into target DNA.
• The dimeric form of HIV-1 IN was only capable of processing and integrating a single viral end.
• Cloning and sequencing confirmed concerted integration by IN tetramers.
• Kinetic studies provided insights into the formation of active DNA-integrase complexes.

Conclusions:

• Tetrameric HIV-1 IN is the minimal functional unit required for concerted integration of both viral LTRs.
• The tetrameric form of HIV-1 IN bound to viral DNA ends is the active complex.
• Targeting the tetrameric IN oligomer is a promising strategy for future drug development against HIV-1.